VERUNasdaqPharmaceutical PreparationsFiscal year ends September 30
VERU INC.
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$2.31+0.01 (+0.43%)
Close on Oct 19, 2026
- Market cap
- $53.25M
- P/E (TTM)
- –
- Dividend yield
- –
VERU statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | VERU | Industry median |
|---|---|---|
| Market Cap | $39.39M | $166.30M |
| Enterprise Value | $15.51M | $88.19M |
| PB Ratio | 1.39 | 2.03 |
| P/TBV Ratio | 1.83 | 2.29 |
Income (trailing twelve months)
| Measure | VERU | Industry median |
|---|---|---|
| Operating Income | -$19.19M | -$21.40M |
| Net Income | -$13.61M | -$22.46M |
| EBITDA | -$19.08M | -$16.91M |
| EPS (Diluted) | -$0.58 | -$0.83 |
Returns
| Measure | VERU | Industry median |
|---|---|---|
| Return on Equity (ROE) | -62.3% | -53.2% |
| Return on Assets (ROA) | -42.3% | -40.9% |
| Return on Invested Capital (ROIC) | -627.7% | -32.4% |
| Return on Capital Employed (ROCE) | -62.2% | -38.1% |
Balance sheet
| Measure | VERU | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $23.88M | $61.43M |
| Net Cash (Debt) | $23.88M | $15.35M |
| Net Cash Per Share | $1.40 | $0.66 |
| Equity (Book Value) | $28.38M | $49.09M |
| Book Value Per Share | $1.66 | $1.37 |
| Tangible Book Value | $21.50M | $23.52M |
| Working Capital | $21.07M | $76.81M |
Financial position
| Measure | VERU | Industry median |
|---|---|---|
| Current Ratio | 4.42 | 3.34 |
| Quick Ratio | 3.88 | 2.44 |
Cash flow (trailing twelve months)
| Measure | VERU | Industry median |
|---|---|---|
| Operating Cash Flow | -$26.04M | -$12.35M |
| Capital Expenditures | $0 | -$1.08M |
| Free Cash Flow | -$26.04M | -$20.22M |
| FCF Per Share | -$1.53 | -$0.42 |
Efficiency
| Measure | VERU | Industry median |
|---|---|---|
| Profits Per Employee | -$680.43K | -$703.34K |
| Employee Count | 20 | 74 |
Dividends and yields
| Measure | VERU | Industry median |
|---|---|---|
| Earnings Yield | -34.6% | -23.3% |
| FCF Yield | -66.1% | -8.72% |
Shares
| Measure | VERU | Industry median |
|---|---|---|
| Shares Outstanding | 17,050,300 | 58,127,000 |
| Shares Change (YoY) | 38.4% | 10.9% |
| Shares Change (QoQ) | 6.23% | 0.54% |
| Float | 1,352,710 | 49,136,700 |
| Shares Held by Insiders | 92.1% | 11.6% |
| Shares Held by Institutions | 17.8% | 59.4% |
Taxes
| Measure | VERU | Industry median |
|---|---|---|
| Income Tax | $0 | $79.87K |
Scores
| Measure | VERU | Industry median |
|---|---|---|
| Altman Z-Score | -10.86 | -0.22 |
| Piotroski F-Score | 2 | 4 |
Calculated by StockData from VERU's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.